Wastewater treatment plants (WWTPs) provide optimal conditions for the maintenance and 28 spread of antibiotic resistant bacteria (ARB) and antibiotic resistance genes (ARGs). In this 29 work we describe the occurrence of antibiotic resistant faecal coliforms and their mechanisms 30 of antibiotic resistance in the effluent of two urban WWTPs in Ireland. Effluent samples were 31 collected from two WWTPs in Spring and Autumn of 2015 and 2016. The bacterial 32 susceptibility patterns to 13 antibiotics were determined. The phenotypic tests were carried 33 out to identify AmpC or extended-spectrum β-lactamase (ESBL) producers. The presence of 34 ESBL genes were detected by PCR. Plasmids carrying ESBL genes were transformed into 35
Introduction

83
The dissemination of antimicrobial resistance within bacterial communities and the selection 84 of new resistance mechanisms are due to the large-scale use of antibiotics in agricultural, 85 veterinary and human clinical applications (1) (2) (3) (4) (5) (6) (7) (8) . The emergence of antibiotic resistant 86 bacteria (ARB) is a major public health issue which poses a serious therapeutic challenge 87 worldwide (6). Wastewater treatment plants (WWTPs) are considered potential sources of 88 ARB and antibiotic resistance genes (ARGs), which play an important role in the spread of 89 antibiotic resistance into the environment (9, 10). The urban WWTPs receive wastewater 90 from human communities, which contains high concentrations of chemical matter, including 91 antibiotics and microorganisms, including ARB. Therefore, WWTPs are favourable 92 environments with optimal conditions for the development and spread of ARB and ARGs 93 (11, 12) . Both ARB and ARGs were detected in wastewater samples globally (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . 94
However, little is known of the fate of these bacteria; and the role of WWTPs in releasing 95 ABR and ARGs into the environment through treated effluent (13) . A recent report by Flach 96 et al shows no evidence for the selection of antibiotic resistance in WWTPs (25); however, 97 large amounts of resistant bacteria were identified throughout the wastewater treatment 98 process (7, 26) . The conventional wastewater treatment process can remove some ARB (27, 99 28), but ARB were still found in large proportions in the effluent (18, 29) . In some cases, 100 ARB were detected at higher rates in WWTP effluent than in the influent (30, 31) . 101
AmpC cephalosporinases and extended-spectrum β-lactamases (ESBLs) are some of the most 102 clinically important antibiotic resistance mechanisms (32) . The dissemination of AmpC or 103 ESBL producing Escherichia coli were identified in different types of aquatic environments, 104 particularly in wastewater (33) (34) (35) (36) . The prevalence of AmpC or ESBL producing bacteria 105 pose a global health problem due to limitations of therapeutic options for the treatment of 106 infections caused by these bacteria (37). The ESBL genes are frequently located on mobile 107 genetic elements (38). Among more than 300 subtypes of ESBL genes, bla TEM and bla SHV 108 groups were the most common ESBL genes identified in human pathogens until the late 109 1990s. These groups were replaced by bla CTX-M genes since the beginning of the 2000s and 110
Escherichia coli became the most prevalent ESBL producing bacteria among clinical 111
Enterobacteriaceae (39). 112
The monitoring of antibiotic resistance from WWTPs provides the information required to 113 track the dissemination of ARB and ARGs into the environment (40, 41) . Moreover, the 114 analysis of ARB and ARGs in urban WWTPs is considered as an alternative method for the 115 indirect study of antibiotic resistance in human populations from which the WWTPs receive 116 wastewater (42). Indeed, the resistance rates of indicator bacteria in wastewater may give 117 useful information to identify the changes in resistance in the human populations (43). The 118 objectives of this study were to characterise the faecal coliforms resistome leaving urban 119
WWTPs via the effluent. This was achieved through i) assessment of the prevalence of 120 antibiotic resistant faecal coliforms in the effluent from two Irish urban WWTPs, ii) 121 characterisation of the antibiotic resistance profiles of these bacteria, iii) identification of the 122 occurrence of AmpC or ESBL producing faecal coliforms and iv) identification of the 123 resistance mechanisms and their potential mobility. 124 125
Materials and Methods
126
Isolation of total faecal coliforms 127
Final effluent samples were collected from two urban WWTPs in Ireland during early Spring 128 and late Autumn in 2015 and 2016. These WWTPs were representative of medium sized 129 WWTPs with 100% urban agglomerations, include tertiary treatment, and the distance 130 between them was less than 100km. Faecal coliforms were isolated using the membrane 131 filtration method (44). The effluent samples (1 mL and 10 mL) were filtered through 132 nitrocellulose membranes (Sigma Aldrich/Merck). The filters were then incubated on mFC 133 agar at 37 o C for 24 hours in the presence or absence of antibiotics: amoxicillin (32 mg/L), 134 ciprofloxacin (1 mg/L) or tetracycline (16 mg/L). All procedures were performed in triplicate. 135
Antibiotic susceptibility test using agar dilution and disk diffusion methods 136
Bacterial isolates were subjected to antibiotic susceptibility testing using the agar dilution 137 method following the CLSI recommendations (45). The antibiotics tested were tetracycline, 138 amoxicillin, ampicillin, ciprofloxacin, kanamycin, gentamicin, colistin, chloramphenicol and 139 trimethoprim. The imipenem, meropenem, cefotaxime and ceftazidime susceptibilities were 140 determined using the disk diffusion method (45). The minimum inhibitory concentration 141 (MIC) breakpoints for Enterobacteriaceae in the CLSI guidelines (45) were used to identify 142 ARB. The EUCAST MIC breakpoint for colistin was used (46). Bacterial isolates resistant to 143 three or more different antibiotic classes of antibiotics were defined as multidrug resistant. 144
The resistance percentages of bacteria were calculated as: percentage (%) = [(Number of 145 resistant faecal coliforms to an antibiotic/ total number of tested faecal coliforms) X 100]. 146
Phenotypic identification of the production of Metallo-beta-lactamase (MBL), ESBL 147
and AmpC enzymes 148 Bacteria resistant to imipenem and/or meropenem were subjected to the Imipenem-EDTA 149 double-disk synergy test as described previously (47) . Isolates resistant to cefotaxime and/or 150 ceftazidime were subjected to ESBL testing following the CLSI guidelines and AmpC testing 151 using phenylboronic acid (45, 48) . 152
Identification of antibiotic resistance genes and bacterial species 153
Putative MBL producing carbapenem resistant isolates (identified using the imipenem-EDTA 154 double-disk synergy test) were subjected to multiplex PCR to identify the carbapenem 155 resistance genes. The primer sets included bla GES , bla GIM , bla IMI , bla IMP , bla KPC , bla NDM , 156 bla OXA-23 , bla OXA-40 , bla OXA-48 , bla OXA-51 , bla OXA-58 , bla VIM (Table 1) (49). Isolates displaying a 157 positive ESBL phenotype and were phenotypically negative for AmpC production were 158 further analysed using the ESBL multiplex-PCR. The primer sets were used to detect the 159 bla TEM , bla SHV , and bla CTX-M-group genes 1, 2, 8, 9, and 25 (Table 1) (50, 51) . 160
Bacterial isolates resistant to colistin were further analysed by for the presence of the plasmid 161 mediated colistin resistance mechanisms. Five primer sets were used to screen for the 162 presence of mcr-1, 2, 3, 4 and 5, as recommended by the EU reference laboratory-163 antimicrobial resistance (Table 1) 
Plasmid transfer by transformation and replicon typing 171
Plasmids were extracted from ESBL positive isolates carrying the bla TEM , bla SHV , and bla CTX-172 M genes using the Macherey-Nagel NucleoSpin plasmid isolation kit. The plasmids were 173 transformed into Escherichia coli DH5α using heat-shock transformation (54, 55). The 174 transformants were selected on LB agar supplemented with ampicillin (32 mg/L). The 175 presence of bla TEM , bla SHV , and bla CTX-M genes in transformants were confirmed by PCR. All 176 transformants were subjected to antimicrobial susceptibility testing against imipenem, 177 meropenem, ertapenem, ciprofloxacin, chloramphenicol, tetracycline, amikacin, gentamycin, 178 kanamycin, trimethoprim and colistin. Replicon typing via PCR were performed on ESBL 179 transformants with 18 pairs of primers recognizing FIA, FIB, FIC, HI1, HI2, I1-Iγ, L/M, N, 180 P, W, T, A/C, K, B/O, X, Y, F, and FIIA in 3 multiplex panels (56). 181 182
Results
183
Antibiotic susceptibility patterns 184
In total, 498 faecal coliforms were isolated from all WWTP effluent samples, comprising 226 185 isolates from WWTP A and 272 from WWTP B. These isolates were subjected to antibiotic 186 susceptibility testing. Among the tested β-lactam antibiotics, more than 90% of bacteria 187 isolated from the two WWTPs were resistant to amoxicillin and ampicillin (Table 2, Figure  188 1); greater than 20% were resistant to cefotaxime or ceftazidime. All ceftazidime resistant 189 isolates were also resistant to cefotaxime. Carbapenem resistance was detected at relatively 190 lower levels (Table 2) . Colistin resistance was found at a higher percentage in WWTP B 191 effluent than in WWTP A. We also identified that there were no differences in the 192 identification of colistin resistant isolates in antibiotic susceptibility testing by the agar 193 dilution method compared to the microbroth dilution method. Multi-drug resistant (MDR) 194 faecal coliforms were detected at approximately 50 % of the total isolates tested ( Table 2) . 195
The resistance prevalence to other antibiotics were found at similar levels between the two 196 WWTPs. 197
Detection of antibiotic resistance genes and speciation 198
Faecal coliforms with resistance to cefotaxime and ceftazidime were considered putative 199 ESBL-producers (n = 157). AmpC production was confirmed in 26 of these isolates ( In total, 79 isolates (36 from WWTP A and 43 from WWTP B) resistant to imipenem were 210 screened for MBL production. Metallo-beta-lactamase production was identified in 36 211
isolates. However, all isolates were negative for known MBL genes, using the MBL 212 multiplex PCR. More than 100 colistin resistant isolates were detected. However, none of 213 these isolates were positive for the mcr-genes using the mcr-targeted PCR analysis. 214
Plasmid transformation, plasmid resistance profile and replicon typing 215
The plasmids were extracted from 62 ESBL faecal coliform isolates (30 from WWTP A and 216 32 from WWTP B). Plasmids extracted from 52 ESBL isolates (46 plasmids carried bla TEM , 2 217 plasmids bla CTX-M15 , 1 bla CTX-M-1 and 3 with bla SHV-12 ) were successfully transferred into E. 218 coli Dh5α recipients. The plasmids extracted from the 10 ESBL isolates (3 with bla TEM , 3 219 with bla CTX-M15 and 4 with bla SHV-12 ) could not be transferred, suggesting that the ESBL genes 220 identified in these isolates are located on the bacterial chromosomes. 221
All transformants were sensitive to the tested carbapenem antibiotics (imipenem, meropenem 222 and ertapenem) and gentamicin, 16 were resistant to chloramphenicol, 16 resistant to 223 tetracycline, 10 resistant to trimethoprim, 3 resistant to colistin, 2 resistant to kanamycin, 1 224 resistant to amikacin and 1 resistant to ciprofloxacin. Nine transformants show a resistance 225 phenotype to two drugs from different classes and eight show a multidrug resistance 226 phenotype. The plasmids from 21 transformants could be typed using PCR replicon typing. 227
Of these, 11 plasmids were IncF replicon type (3 IncFIA, 1 IncFIIA, 1 IncFIB and 6 non-228 specific IncF group), 5 were IncI1 replicon type, 2 were IncHI1 replicon type, 2 were IncHI2 229 replicon type and 1 was IncA/C replicon type. The IncF group of replicons was the most 230 prevalent across plasmids from both WWTPs. The IncI1 type was detected only in bacteria 231 isolated from the WWTP B effluent samples. 232
233
Discussion
234
Our work presents the antibiotic resistance patterns of faecal coliforms in the effluent of two 235 WWTPs in Ireland. Wastewaters with faecal contamination are considered reservoirs for 236 ARB and ARGs in the environment (57, 58). Among all tested antibiotics, resistance to 237 amoxicillin and ampicillin was most prevalent, followed by tetracycline and, cefotaxime and 238 ciprofloxacin. High levels of β-lactam resistance were previously detected in 239
Enterobacteriaceae in an urban WWTP (59), and resistance to tetracycline and 240 fluoroquinolones was found at lower rates. The higher resistance rate of E. coli to ampicillin 241 and tetracycline as well as lower rates of resistance to ciprofloxacin were detected in WWTPs 242 in Portugal (60). A study of raw sewage in Brazil identified 100% sensitivity of E. coli to 243 ciprofloxacin and amoxicillin and tetracycline resistance levels in the range of 50 -75% (61). 244
The proportions of ciprofloxacin resistant faecal coliforms were 31.42% in WWTP A effluent 245 and 26.47% in WWTP B. This resistance rate is higher in comparison to reported levels of 246 ciprofloxacin resistance in the E. coli isolated from other WWTPs (59, 62, 63) . In general, 247 differences in antibiotic resistance percentages were observed between the two WWTPs, 248 particularly for colistin, trimethoprim and kanamycin ( Figure 1 ). As these two WWTPs are 249 using the same treatment process, this difference may be associated with their location or 250 other external factors. resistance phenotypes in our work were considered high in comparison to previous studies in 265 wastewater (33, 77) . However, there were no known carbapenem resistance genes detected in 266 the carbapenem resistant coliforms. This suggests that other resistance mechanisms are 267 responsible for the resistance phenotypes and thus require further study to characterise these 268 novel mechanisms. 269
Multi-drug resistant faecal coliforms were retrieved at high rates from all effluent samples. In 270 the study of Lefkowitz and Durán (78) , 60% of E. coli in WWTP effluent were resistant to 271 two or more antibiotics and 25% to four or more antibiotics. The study of Garcia et al (79) in 272 WWTP effluent showed no more than 12% of E. coli were resistant to two antibiotics and 273 less than 10% to three or more antibiotics. Escherichia coli (34.3%) were found to be 274 resistant to two or more antibiotics and 8.8% to four or more antibiotics in treated wastewater 275 in Portugal (59). The MDR faecal coliforms in our study were found in the same range of the 276 study of Lefkowitz and Durán, but at a higher percentage than in others. 277
The ESBLor AmpC producing faecal coliforms were recovered from all WWTP effluent 278 samples. The rate of ESBL producing Enterobacteriacea in our work were within the range 279 of previous studies. It was considerably high in comparison to some studies of WWTP 280 effluent (0.5-9.8%) (34, 80-83). However it was lower than those studies in wastewater (45-281 100%) (84, 85). The high load of bacteria and rich nutrient environment in WWTPs 282 facilitates the transfer of ARGs among bacteria (11, 12) . These may explain the relatively 283 high rates of ESBL producers in WWTP effluent. 284
The bla TEM were the most prevalent beta-lactamase in this study, which is similar to a study 285 on hospital wastewater in Brazil (85). However, this is in contrast with other findings with 286 bla CTX-M being the most frequent ESBL genes from various samples including in hospital 287 effluent, surface water and WWTPs (34, 39, 86) . This result was confirmed by qPCR data 288 performed in another study in the framework of the StARE project which showed the 289 detection of bla TEM genes, where bla SHV and bla CTX-M group 1 were not detected (22). Most of 290 ESBL genes were found in E. coli, others were carried by Klebsiella spp. in our work. These 291 results are in an agreement with previous findings which indicated that E. coli were the most 292 common ESBL-producers among Enterobacteriaceae (39). 293 Transformation of plasmids carrying ESBL genes were successful for 88% of ESBL donor 294 isolates in this work. Different replicon variants were found in the ESBL plasmids. The most 295 prevalent replicon was IncF group which were also reported in other studies of plasmid 296 replicon typing in Enterobacteriaceae (87-89). These replicons have a narrow host range and 297 can be transfer easily among E. coli species (90). The cross-resistance of ESBL producers to 298 other antibiotic causes of great concern as ESBL genes are frequently located on conjugative 299 plasmids carrying other ARGs (91). In this work eight of 52 transferable plasmids carrying 300 ESBL genes expressed a MDR phenotype. final extension for 7 min at 72 o C. 6 5 bla 3 2 bla TEM-1-like (>99% identical to bla 
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multiplex 1 bla VIM -(F) GATGGTGTTTGGTCGCATATC (R) CGTCATGAAAGTGCGTGGAG bla KPC -(F) CGCCAATTTGTTGCTGAAGG (R) CAGGTTCCGGTTTTGTCTCC bla OXA-40-( F) AGTTTCTCTCAGTGCATGTTCA (R) CCCGCTTTACTTCTTTCTGCA bla NDM -(F) GTTTGATCGTCAGGGATGGC (R) CTCATCACGATCATGCTGGC bla OXA-48 -(F) GGTAGCAAAGGAATGGCAAGAA (R) CGACCCACCAGCCAATCTTA
